16-bromoepiandrosterone has been researched along with Malaria, Falciparum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arese, P; Ayi, K; Giribaldi, G; Prendergast, PT; Schwarzer, E; Skorokhod, A | 1 |
| Frincke, JM; Garsd, A; Krudsood, S; Looareesuwan, S; Onizuka-Handa, N; Reading, C; Stickney, DR; Wilairatana, P | 1 |
1 trial(s) available for 16-bromoepiandrosterone and Malaria, Falciparum
| Article | Year |
|---|---|
Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000.
Topics: Adult; Androsterone; Animals; Body Temperature; Female; Humans; Immunologic Factors; Kaplan-Meier Estimate; Malaria, Falciparum; Male; Parasitemia; Plasmodium falciparum; Thailand | 2007 |
1 other study(ies) available for 16-bromoepiandrosterone and Malaria, Falciparum
| Article | Year |
|---|---|
16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity.
Topics: Adult; Androsterone; Animals; Antimalarials; Cell Membrane; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Erythrocytes; Female; Humans; Malaria, Falciparum; Male; Parasitic Sensitivity Tests; Phagocytosis; Phosphatidylserines; Plasmodium falciparum | 2002 |